Clinical Trials
5 trialsNCT04472468 2024-11-05
PMAP
Chinese University of Hong Kong
Phase NA Terminated
NCT00347412 2022-07-25
Study of NOV-002 in Combination With Chemotherapy to Treat Lung Cancer
Cellectar Biosciences, Inc.
Phase 3 Completed
NCT05077111 2021-10-14
VATS
Ain Shams University
Phase 4 Unknown
NCT02054052 2019-03-29
Intrapleural Bevacizumab Injection for Malignant Effusion in Lung Cancer
Guangzhou Medical University
Phase 2 Completed
NCT00508144 2017-02-13
Single Agent Alimta in Poor Performance Status in Non-small Cell Lung Cancer
M.D. Anderson Cancer Center
Phase 2 Completed